Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,912 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
Peoples GE, Holmes JP, Hueman MT, Mittendorf EA, Amin A, Khoo S, Dehqanzada ZA, Gurney JM, Woll MM, Ryan GB, Storrer CE, Craig D, Ioannides CG, Ponniah S. Peoples GE, et al. Among authors: amin a. Clin Cancer Res. 2008 Feb 1;14(3):797-803. doi: 10.1158/1078-0432.CCR-07-1448. Clin Cancer Res. 2008. PMID: 18245541 Clinical Trial.
Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
Amin A, Benavides LC, Holmes JP, Gates JD, Carmichael MG, Hueman MT, Mittendorf EA, Storrer CE, Jama YH, Craig D, Stojadinovic A, Ponniah S, Peoples GE. Amin A, et al. Cancer Immunol Immunother. 2008 Dec;57(12):1817-25. doi: 10.1007/s00262-008-0509-2. Epub 2008 Apr 8. Cancer Immunol Immunother. 2008. PMID: 18392824 Free PMC article. Clinical Trial.
Clinical and immunologic responses of HLA-A3+ breast cancer patients vaccinated with the HER2/neu-derived peptide vaccine, E75, in a phase I/II clinical trial.
Patil R, Clifton GT, Holmes JP, Amin A, Carmichael MG, Gates JD, Benavides LH, Hueman MT, Ponniah S, Peoples GE. Patil R, et al. Among authors: amin a. J Am Coll Surg. 2010 Feb;210(2):140-7. doi: 10.1016/j.jamcollsurg.2009.10.022. Epub 2009 Dec 22. J Am Coll Surg. 2010. PMID: 20113933 Clinical Trial.
Trachoma Impact Survey Results from 31 Woredas in Tigray Region, Ethiopia.
Teferi G, Adane H, Cyrille E, Tefera A, Gadisa S, Amin A, Tsehaye M, Mitku Y, Assefa H, Backers S, Alemayehu A, Mengistu B, Kebede F, Tadesse F, Negussu N, Butcher R, Bakhtiari A, Willis R, Boyd S, Jimenez C, Dejene M, Solomon AW, Deyassa M, Shafi M, Kifle T, Tegen A, Mesfin B, Berihu T, Mariam T, Godefay H, Harding-Esch EM, Kidane A, Fisseha E. Teferi G, et al. Among authors: amin a. Ophthalmic Epidemiol. 2024 Dec;31(6):597-604. doi: 10.1080/09286586.2024.2317823. Epub 2024 Dec 27. Ophthalmic Epidemiol. 2024. PMID: 39729339
2,912 results